Literature DB >> 869969

Lymphotoxic effect of cyclophosphamide in therapy of Ehrlich ascites carcinoma in mice.

F Culo, N Allegretti, M Marusić.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 869969     DOI： 10.1093/jnci/58.6.1759

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Novel combination of 2-methoxyestradiol and cyclophosphamide enhances the antineoplastic and pro-apoptotic effects on S-180 ascitic tumour cells.

Authors:  Srabantika Mallick; Atish Barua; Goutam Paul; Samarendra Nath Banerjee
Journal:  J Cell Commun Signal       Date:  2017-08-10       Impact factor: 5.782

2.  Delayed toxicity of cyclophosphamide in normal mice.

Authors:  E Anton
Journal:  Br J Exp Pathol       Date:  1987-04

3.  The influence of cyclophosphamide on antitumor immunity in mice bearing late-stage tumors.

Authors:  F Culo; I Klapan; T Kolak
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

4.  Interference of anti-tumor and immunosuppressive effects of cyclophosphamide in tumor-bearing rats. Analysis of factors determining resistance or susceptibility to a subsequent tumor challenge.

Authors:  D Vidović; M Marusić; F Culo
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.